Health

Retail pharmacy, often characterized by bustling counters and quick transactions, hides a significant challenge beneath its surface: the physical and psychological toll it takes on its workers. As I reflect on my tenure in this field, especially during my internship in 2016, I am reminded of the long hours and grueling conditions that many pharmacy

Multiple sclerosis (MS) is a complex neurological condition that predominantly affects young adults, with varying degrees of severity and course among individuals. Recent research has illuminated a concerning trend in the treatment of relapsing forms of MS: women, who account for a significant proportion of MS patients, are less likely than men to receive appropriate

The Federal Trade Commission (FTC) has initiated a lawsuit against three major pharmacy benefit managers (PBMs)—Caremark, Express Scripts, and OptumRx—accusing them of employing anti-competitive practices that have significantly increased insulin prices for individuals living with diabetes. PBMs, which are responsible for administering prescription drug benefits for health insurers and large employers, control a substantial share

In the intricate realm of American healthcare, political influence, personal anecdotes, and scientific advancements weave a complex tapestry that defines public health outcomes. As we approach the upcoming elections, the role of political figures, such as Robert F. Kennedy Jr., raises significant questions about the future direction of health policymaking in the United States. The

In recent months, a plethora of health studies and findings have drawn significant attention on various fronts, from the benefits of coffee consumption to the repercussions of specific health policies. This article aims to synthesize and analyze these significant developments, emphasizing their implications and our evolving understanding of health and wellness. A comprehensive analysis from

The recent approval of ribociclib (Kisqali) by the U.S. Food and Drug Administration (FDA) marks a significant milestone in the management of early high-risk breast cancer. Previously indicated for metastatic breast cancer, ribociclib is now authorized for use as an adjuvant therapy in patients presenting with hormone receptor-positive and HER2-negative tumors, specifically those classified as

Muscle-invasive bladder cancer (MIBC) remains one of the most challenging urological malignancies, often leading to significant morbidity and mortality among patients. Recent advancements in immunotherapy present new therapeutic potentials for this condition. A pivotal Phase III trial known as NIAGARA has provided compelling evidence that the integration of durvalumab (Imfinzi) with neoadjuvant chemotherapy can significantly

Squamous cell carcinoma of the anal canal (SCAC) remains a significant medical concern. This type of cancer is often neglected, classified under “orphan diseases,” yet it has shown a disturbing increase in incidence, primarily due to the prevalence of human papillomavirus (HPV) infections. This article delves into the recent findings surrounding the use of retifanlimab,

Menopause marks a pivotal transition in a woman’s life, characterized by significant hormonal fluctuations and various health implications. Notably, this phase is linked to an increased risk of insulin resistance, which can set the stage for various metabolic disorders. A recent systematic review and meta-analysis presented at the Menopause Society annual meeting sheds light on

Recent statements made by former President Donald Trump regarding free in vitro fertilization (IVF) treatments have sparked significant backlash within Republican circles. This pledge raises questions about the party’s stance on reproductive health issues and how such promises might shape voter perspectives. The stark division within the party reflects broader debates in the United States